JCM
DAWN

Jacobi Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Jacobi Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$5K – 607
2021
Q3 		$5K Buy
+200
New +$4.79K ﹤0.01% 1191

Other funds holding DAWN

CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jacobi Capital Management's DAWN Position: Q4 2021 in Review

Jacobi Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q4 2021, closing a stake of 200 shares — an estimated $5K sold.

Jacobi Capital Management first reported a position in DAWN in Q3 2021 and held it in 1 quarter. The position peaked at $5K in Q3 2021. 58 funds tracked by Wall St. Rank hold DAWN as of Q4 2021.

  • Jacobi Capital Management reported no remaining Day One Biopharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 200 Day One Biopharmaceuticals shares in Q4 2021, an estimated $5K.
  • Jacobi Capital Management first reported a position in Day One Biopharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Jacobi Capital Management's Day One Biopharmaceuticals position peaked at $5K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.